| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2081788 | Drug Discovery Today: Disease Mechanisms | 2010 | 6 Pages |
Abstract
Obesity has become an epidemic and its prevalence is increasing exponentially. A great deal of focus has been given to understanding the molecular processes that regulate obesity. The characterization of phospholipase A2s, especially adipose-specific PLA2, has lead to a proposed role of their downstream products in the progression of obesity and obesity related disorders. This review summarizes recent developments in the role of PLA2 and their downstream effects in the development of metabolic disorders.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Marcia J. Abbott, Tianyi Tang, Hei Sook Sul,